01 1Auro Peptides Limited
01 1TERIPARATIDE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-19
Pay. Date : 2018-08-13
DMF Number : 33079
Submission : 2018-08-17
Status : Active
Type : II
20
Auro Peptides Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TERIPARATIDE, with a corresponding US DMF Number 33079.
Remarkably, this DMF maintains an Active status since its submission on August 17, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 19, 2018, and payment made on August 13, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
